| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | 160,601 | 100,530 |
| Bad debt expense (benefit) | 1,004 | 236 |
| Depreciation and amortization | 8,515 | 5,539 |
| Equity-based compensation | 168,009 | 127,843 |
| Deferred tax provision (benefit) | 28,658 | 6,662 |
| Gain on partial sale of equity method investment | 19,092 | - |
| Other | 11,743 | 845 |
| Accounts receivable | 4,660 | 3,529 |
| Accrued and other receivables | 21,850 | 23,771 |
| Prepaid expenses and other assets | 7,464 | 1,070 |
| Deferred compensation | 12,578 | 17,491 |
| Compensation payable | -54,424 | -158,436 |
| Accounts payable, accrued expenses and other liabilities | 2,618 | -90 |
| Deferred revenue | -2,387 | 1,486 |
| Dividends received | 2,347 | 1,623 |
| Net cash provided by (used in) operating activities | 237,554 | 38,687 |
| Purchases of investments | 408,523 | 256,737 |
| Proceeds from sales of investments | 219,398 | 151,398 |
| Note payments received from (issued to) employees | 138 | 138 |
| Proceeds from partial sale of equity method investment | 29,916 | - |
| Purchases of equipment and leasehold improvements | 27,171 | 7,856 |
| Net cash provided by (used in) investing activities | -186,242 | -113,057 |
| Payments for dividends and tax distributions | 155,609 | 104,212 |
| Payments for treasury stock purchases | 28,468 | 13,270 |
| Payments under tax receivable agreement | 314 | 314 |
| Net cash provided by (used in) financing activities | -184,391 | -117,796 |
| Effect of exchange rate fluctuations on cash, cash equivalents, and restricted cash | 2,335 | 1,503 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -130,744 | -190,663 |
| Cash and cash equivalents at beginning of period | 413,179 | - |
| Cash and cash equivalents at end of period | 282,435 | - |
Moelis & Co (MC)
Moelis & Co (MC)